<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mustafa F</submitter><funding>ASPIRE Grant</funding><funding>Al Jalila Foundation</funding><funding>ATRC</funding><pagination>30815</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371099</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>This study aimed to identify miRNA-based biomarkers in a multi-ethnic cohort of SARS-CoV-2-infected individuals to enhance preparedness for future variants of concern. A total of 31 healthy controls and 154 infected patients were enrolled, from which 13 matched controls and 38 infected nasal swab samples were analyzed using miRNA sequencing, followed by qRT-PCR validation. Among the 1788 miRNAs detected, 14 differentially expressed miRNAs and four novel miRNAs were identified, with novel-miR-264-5p showing a ≥ 2-fold change. Correlation with clinical markers highlighted several miRNAs as potential prognostic biomarkers. Seven miRNAs, including miR-146b-3p, miR-154-5p, miR-5010-3p, miR-127-3p, miR-335-3p, miR-30c-5p, and miR-202-5p, showed strong prognostic potential. Combined ROC analysis </pubmed_abstract><journal>Scientific reports</journal><pubmed_title>miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infection.</pubmed_title><pmcid>PMC12371099</pmcid><funding_grant_id>AARE20-344</funding_grant_id><funding_grant_id>AJF2020006</funding_grant_id><funding_grant_id>VRI-20-10</funding_grant_id><pubmed_authors>Baby J</pubmed_authors><pubmed_authors>Panicker NG</pubmed_authors><pubmed_authors>Baki HA</pubmed_authors><pubmed_authors>Salim AM</pubmed_authors><pubmed_authors>Khader TA</pubmed_authors><pubmed_authors>Habous M</pubmed_authors><pubmed_authors>Rehman E</pubmed_authors><pubmed_authors>Jaballah S</pubmed_authors><pubmed_authors>Khansaheb HH</pubmed_authors><pubmed_authors>Alqassim SS</pubmed_authors><pubmed_authors>Ahmad W</pubmed_authors><pubmed_authors>Gull B</pubmed_authors><pubmed_authors>AlDabal LMJA</pubmed_authors><pubmed_authors>Rizvi TA</pubmed_authors><pubmed_authors>Mustafa F</pubmed_authors><pubmed_authors>Alsheikh-Ali A</pubmed_authors><pubmed_authors>Ahmed RLG</pubmed_authors></additional><is_claimable>false</is_claimable><name>miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infection.</name><description>This study aimed to identify miRNA-based biomarkers in a multi-ethnic cohort of SARS-CoV-2-infected individuals to enhance preparedness for future variants of concern. A total of 31 healthy controls and 154 infected patients were enrolled, from which 13 matched controls and 38 infected nasal swab samples were analyzed using miRNA sequencing, followed by qRT-PCR validation. Among the 1788 miRNAs detected, 14 differentially expressed miRNAs and four novel miRNAs were identified, with novel-miR-264-5p showing a ≥ 2-fold change. Correlation with clinical markers highlighted several miRNAs as potential prognostic biomarkers. Seven miRNAs, including miR-146b-3p, miR-154-5p, miR-5010-3p, miR-127-3p, miR-335-3p, miR-30c-5p, and miR-202-5p, showed strong prognostic potential. Combined ROC analysis </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-04-08T09:09:54.63Z</modification><creation>2026-04-08T00:46:53.761Z</creation></dates><accession>S-EPMC12371099</accession><cross_references><pubmed>40841549</pubmed><doi>10.1038/s41598-025-15248-6</doi></cross_references></HashMap>